継続事業からの当期純利益、剰余金の配当、持分法適用会社への投資額 - 医療関連事業他2件
- 【期間】
| 年度 | 継続事業からの当期純利益 | 剰余金の配当 | 持分法適用会社への投資額 - 医療関連事業 | 減損損失 - デジタル＆インダストリー | 償却原価で測定する金融資産 |
|---|
| 2017/03 | - | | - | | 96.1億 | | - | | - | |
| 2018/03 | - | | - | | 96.1億 | ±0% | - | | - | |
| 2018/06 | 64.7億 | | - | | - | | - | | - | |
| 2018/09 | 125億 | +93.9% | - | | - | | - | | - | |
| 2018/12 | 206億 | +63.9% | - | | - | | - | | - | |
| 2019/03 | 310億 | +50.6% | - | | 99.1億 | +3.1% | - | | 147百万 | |
| 2019/06 | 76.8億 | -75.2% | - | | - | | - | | - | |
| 2019/09 | 145億 | +89.4% | - | | - | | - | | - | |
| 2019/12 | 267億 | +83.7% | - | | - | | - | | - | |
| 2020/03 | 337億 | +26.3% | - | | - | | - | | 167百万 | +13.6% |
| 2020/06 | 52.3億 | -84.5% | - | | - | | - | | - | |
| 2020/09 | 118億 | +125.2% | - | | - | | - | | - | |
| 2020/12 | 232億 | +97.1% | - | | - | | - | | - | |
| 2021/03 | 304億 | +30.7% | - | | - | | - | | 200百万 | +19.8% |
| 2021/06 | 115億 | -62% | - | | - | | - | | - | |
| 2021/09 | 224億 | +94% | - | | - | | - | | - | |
| 2021/12 | 343億 | +53.4% | - | | - | | - | | - | |
| 2022/03 | 464億 | +35.3% | - | | - | | - | | 263百万 | +31.5% |
| 2022/06 | 84.6億 | -81.8% | - | | - | | - | | - | |
| 2022/09 | 166億 | +96.8% | - | | - | | - | | - | |
| 2022/12 | 267億 | +60.3% | - | | - | | - | | - | |
| 2023/03 | 430億 | +60.9% | - | | - | | 19百万 | | 488百万 | +85.6% |
| 2023/06 | 73.6億 | -82.9% | - | | - | | - | | - | |
| 2023/09 | 179億 | +143.2% | - | | - | | - | | - | |
| 2023/12 | 324億 | +80.9% | - | | - | | - | | - | |
| 2024/03 | 461億 | +42.4% | - | | - | | 0 | -100% | 670百万 | +37.3% |
